ORPHENADRINE CITRATE Drug Patent Profile
✉ Email this page to a colleague
When do Orphenadrine Citrate patents expire, and what generic alternatives are available?
Orphenadrine Citrate is a drug marketed by Hikma, Rising, Sagent Pharms, Watson Labs, Ascot, Bayshore Pharms Llc, Lupin, Sandoz, and Stevens J. and is included in fifteen NDAs.
The generic ingredient in ORPHENADRINE CITRATE is aspirin; caffeine; orphenadrine citrate. There are twenty-two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the aspirin; caffeine; orphenadrine citrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ORPHENADRINE CITRATE?
- What are the global sales for ORPHENADRINE CITRATE?
- What is Average Wholesale Price for ORPHENADRINE CITRATE?
Summary for ORPHENADRINE CITRATE
| US Patents: | 0 |
| Applicants: | 9 |
| NDAs: | 15 |
| Finished Product Suppliers / Packagers: | 20 |
| Raw Ingredient (Bulk) Api Vendors: | 81 |
| Patent Applications: | 869 |
| Drug Prices: | Drug price information for ORPHENADRINE CITRATE |
| DailyMed Link: | ORPHENADRINE CITRATE at DailyMed |
Pharmacology for ORPHENADRINE CITRATE
| Drug Class | Muscle Relaxant |
| Physiological Effect | Centrally-mediated Muscle Relaxation |
US Patents and Regulatory Information for ORPHENADRINE CITRATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | ORPHENADRINE CITRATE | orphenadrine citrate | INJECTABLE;INJECTION | 040463-001 | Mar 4, 2003 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Bayshore Pharms Llc | ORPHENADRINE CITRATE | orphenadrine citrate | TABLET, EXTENDED RELEASE;ORAL | 091158-001 | Jul 27, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Watson Labs | ORPHENADRINE CITRATE | orphenadrine citrate | INJECTABLE;INJECTION | 084779-001 | Mar 15, 1982 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Stevens J | ORPHENADRINE CITRATE | orphenadrine citrate | TABLET, EXTENDED RELEASE;ORAL | 040368-001 | Jun 23, 2000 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lupin | ORPHENADRINE CITRATE | orphenadrine citrate | TABLET, EXTENDED RELEASE;ORAL | 040284-001 | Jun 19, 1998 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Stevens J | ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE | aspirin; caffeine; orphenadrine citrate | TABLET;ORAL | 074988-001 | Apr 30, 1999 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
